# Delving Into Borderline Personality Disorder Clinical Trial Experiences

> **NCT05989529** · — · NOT_YET_RECRUITING · sponsor: **Power Life Sciences Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Borderline Personality Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05989529
- **Lead sponsor:** Power Life Sciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09
- **Primary completion:** 2025-09
- **Final completion:** 2026-09
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05989529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05989529, "Delving Into Borderline Personality Disorder Clinical Trial Experiences". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05989529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*